Fund shareholders of Standard BioTools Inc
ISIN US34385P1084 · United States · LEI 549300GX8Y96GSB6YP89
- Fund shareholders
- 104
- Of which ETFs
- 20 84 other funds
- Value held
- 43.6M $
- Share of capital
- 11.5 % of 392.6M shares on Aug 3, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| ProShares Hedge Replication ETF ProShares Trust | 307 | 346.9 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Longview Advantage ETF RBB Fund Trust | 222 | 250.9 $ | 0.00 % | as of Feb 28, 2026 ↗ | |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 93 | 105.1 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 74 | 68 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.35 % | as of Feb 28, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 0.26 % | as of Feb 28, 2026 ↗ |
| Inception Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 0.25 % | as of Mar 31, 2026 ↗ |
| Royce Micro-Cap Fund ROYCE FUND | 0.25 % | as of Mar 31, 2026 ↗ |
| Royce Capital Fund - Micro-Cap Portfolio ROYCE CAPITAL FUND | 0.25 % | as of Mar 31, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 0.12 % | as of Mar 31, 2026 ↗ |
| Neuberger Intrinsic Value Fund NEUBERGER BERMAN EQUITY FUNDS | 0.09 % | as of Feb 28, 2026 ↗ |
| Tarkio Fund Clark Fork Trust | 0.06 % | as of Feb 28, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.05 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 0.03 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 104 | 0 | 45,304,965 | -11.8 % |
| 2026Q1 | 104 | +2 | 51,342,084 | +2.4 % |
| 2025Q4 | 102 | -2 | 50,130,795 | -2.4 % |
| 2025Q3 | 104 | -12 | 51,372,405 | -6.0 % |
| 2025Q2 | 116 | -3 | 54,638,221 | -4.6 % |
| 2025Q1 | 119 | +6 | 57,279,776 | +1.4 % |
| 2024Q4 | 113 | +46 | 56,506,023 | +19.2 % |
| 2024Q3 | 67 | +17 | 47,409,517 | +18.4 % |
| 2024Q2 | 50 | +3 | 40,053,792 | +46.5 % |
| 2024Q1 | 47 | +21 | 27,337,043 | +119.1 % |
| 2023Q4 | 26 | 12,475,523 |
Institutional managers
148 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Casdin Capital, LLC | 88,783,856 | 81.6M $ | as of Mar 31, 2026 |
| VIKING GLOBAL INVESTORS LP | 58,651,170 | 53.9M $ | as of Mar 31, 2026 |
| MAK CAPITAL ONE LLC | 26,172,626 | 24.1M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 24,756,084 | 22.8M $ | as of Mar 31, 2026 |
| Long Focus Capital Management, LLC | 16,015,721 | 14.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 7,289,336 | 6.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 6,556,509 | 6M $ | as of Mar 31, 2026 |
| Hollow Brook Wealth Management LLC | 5,653,381 | 5.2M $ | as of Mar 31, 2026 |
| NEUBERGER BERMAN GROUP LLC | 4,657,585 | 4.3M $ | as of Mar 31, 2026 |
| Tikvah Management LLC | 3,551,152 | 3.3M $ | as of Mar 31, 2026 |
| ROYCE & ASSOCIATES LP | 3,005,529 | 2.8M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,887,146 | 2.7M $ | as of Mar 31, 2026 |
| BARCLAYS PLC | 2,617,969 | 2.4M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 2,454,235 | 2.3M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,414,699 | 2.2M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 2,102,015 | 1.9M $ | as of Mar 31, 2026 |
| Peapod Lane Capital LLC | 2,028,527 | 1.9M $ | as of Mar 31, 2026 |
| Sone Capital Management, LLC | 1,766,781 | 1.6M $ | as of Mar 31, 2026 |
| Slate Path Capital LP | 1,615,000 | 1.5M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,225,310 | 1.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 943,185 | 867.1K $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 933,098 | 857.8K $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 766,953 | 705.1K $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 704,407 | 647.6K $ | as of Mar 31, 2026 |
| Nuveen, LLC | 661,204 | 607.8K $ | as of Mar 31, 2026 |
Declared shareholders of Standard BioTools Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Casdin Capital, LLC and 5 others | 23.90 % | 93,845,778 | as of Jun 6, 2026 · SCHEDULE 13D |
| VIKING GLOBAL INVESTORS LP and 9 others | 15.00 % | 58,651,170 | as of Jun 6, 2026 · SCHEDULE 13D |
| MAK Capital Fund LP and 2 others | 6.70 % | 26,172,626 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Standard BioTools Inc". https://titelia.com/en/stocks/standard-biotools-inc-US34385P1084